Please login to the form below

Not currently logged in
Email:
Password:

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.

Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.

Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.

She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.

Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.

“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.

Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

1st May 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics